Course of treatment for leukemia using venetoclax/venetoclax

While patients with leukemia are taking Venetoclax/Venetoclax, the treatment course is an individualized process based on the individual situation and pathological type. Generally speaking, Venetoclax/Venetoclax is an oral drug, and patients need to take it daily according to the doctor's advice and prescription. The initial course of treatment may involve titration, i.e., starting with a low dose and gradually increasing it to reduce possible side effects and improve tolerability. Doctors will conduct regular evaluations based on the patient's response and changes in condition, and adjust the treatment plan accordingly. The length of treatment varies based on individual circumstances and may take several weeks to several months. Patients need to undergo regular blood tests during the course of treatment to monitor white blood cell counts and other indicators to ensure the effectiveness of treatment. Closely following your doctor's advice and promptly reporting any changes in symptoms are critical steps to ensure successful treatment and patient safety.